US Edition
Published • loading... • Updated
One Man, His Dog, and ChatGPT: Australia's AI Vaccine Saga
An Australian man used AI tools including ChatGPT to develop a custom mRNA vaccine for his dog, leading to partial remission of terminal mast cell cancer, researchers said.
- On Monday, Australian AI consultant Paul Conyngham revealed he used artificial intelligence to design a personalized experimental treatment for his eight-year-old rescue dog, Rosie, who had terminal mast cell cancer.
- After Rosie's cancer was misdiagnosed for nearly a year, Conyngham turned to ChatGPT and other AI models to research therapies, spending $3,000 to sequence her genome and analyze DNA data.
- Utilizing AlphaFold, which won 2024's chemistry Nobel, Conyngham collaborated with UNSW to create and administer the custom mRNA vaccine targeting her mutated genes.
- Rosie's largest tumor has shrunk dramatically and she is in partial remission, though UNSW director Pall Thordarson cautioned the "short answer is we don't know for sure" what caused the reduction.
- OpenAI boss Sam Altman called the effort an "amazing story" on Friday, yet experts like Assistant Professor Nick Semenkovich noted the lack of published scientific details makes it difficult to verify the vaccine's efficacy.
Insights by Ground AI
19 Articles
19 Articles
OpenAI's Sam Altman and Science VP Kevin Weil hype AI-assisted dog cancer story ignoring there's no proof the vaccine worked
An Australian AI consultant used ChatGPT, AlphaFold, and Grok to find a possible treatment for his dog Rosie's incurable cancer. The story went viral after high-profile AI executives like OpenAI's Greg Brockman and Deepmind's Demis Hassabis shared it as proof of what AI can already do. But there's no evidence the AI-designed vaccine actually worked. The article OpenAI's Sam Altman and Science VP Kevin Weil hype AI-assisted dog cancer story ignor…
Coverage Details
Total News Sources19
Leaning Left2Leaning Right6Center5Last UpdatedBias Distribution46% Right
Bias Distribution
- 46% of the sources lean Right
46% Right
15%
C 39%
R 46%
Factuality
To view factuality data please Upgrade to Premium
